论文信息 - Depth of Response to Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (Isa-KRd) in Front-Line Treatment of High-Risk Multiple Myeloma: Interim Analysis of the GMMG-CONCEPT Trial - 字舞流文

Depth of Response to Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (Isa-KRd) in Front-Line Treatment of High-Risk Multiple Myeloma: Interim Analysis of the GMMG-CONCEPT Trial

H. Goldschmidt | A. Jauch | Y. Ko | C. Bokemeyer | M. Görner | A. Benner | D. Tichy | P. Staib | M. Munder | H. Reinhardt | U. Graeven | H. Salwender | K. Weisel | M. Haenel | A. Asemissen | I. Blau | R. Lutz | R. Peceny | L. Leypoldt | M. Zago | B. Besemer | C. Mann